
MedEngine acquires the Institute of Applied Economics and Health Research ApS (ApHER) to offer Nordic real-world data solutions to global pharmaceutical companies
The Institute of Applied Economics and Health Research (ApHER) provides research services in the fields of pharmacoepidemiology, real-world evidence, and health economics for pharmaceutical companies. With this strategic acquisition, MedEngine obtains a strong presence across Nordic countries and broadens its scientific expertise. MedEngine will have offices in Helsinki (Finland), Copenhagen (Denmark), and Lund (Sweden) as well as an extensive scientific network across the region.
“This is an important step in the implementation of our international expansion strategy, which is based on building industry-leading medical data science solutions for global pharma customers by leveraging the power of Nordic real-world data. ApHER is well-known for the pan-Nordic registry studies, with an outstanding scientific track record. We are thrilled to join forces with some of the leading experts in the field”, says Tero Ylisaukko-oja, CEO of MedEngine.
“With its scientific mindset and a strong drive for growth, MedEngine is an optimal owner for ApHER”, says CEO of ApHER, Peter Gerhardsson: ”Our team is very excited to be a part of building a next-generation medical research organization.”
Through the acquisition, MedEngine further strengthens its expertise in medical data science services, which include real-world evidence research, post-authorization safety studies, health-economic research, external control arm solutions for clinical trials, machine-learning-based real-world data solutions, and qualitative research. The acquisition also accelerates the expansion of MedEngine’s medical content solutions and market access services to Denmark and Sweden.
About MedEngine
MedEngine is a digitally minded, people-first, premium service provider for the pharmaceutical industry, which is built upon extensive academic expertise and years of experience in the industry. MedEngine creates strategic solutions to accelerate medical business by combining services in the fields of Medical Data Science, Market Access, and Medical Content Solutions. MedEngine’s customers are the world’s leading pharmaceutical and health technology companies and innovative healthcare start-up companies.
For more information, please visit www.medengine.fi or follow us on Twitter @MedEngineAgency.
About ApHER
The Institute of Applied Economics ApS (ApHER) is based in Copenhagen, Denmark and conducts research and provides strategic consulting services in Health Economics and Outcomes Research, Pharmacoepidemiology, and Real-World Evidence. The company works within a network of academic and industry professionals in the Nordic countries and services global pharmaceutical and medical technology customers.
For more information, please visit www.appliedeconomics.dk
Contacts
For additional information:
Tero Ylisaukko-oja
MedEngine Oy
CEO, Founder
tero@medengine.fi
+358 40 901 2975
Links
About MedEngine Oy
MedEngine is a digitally minded, people-first, premium service provider for the pharmaceutical industry, which is built upon extensive academic expertise and years of experience in the industry. MedEngine creates strategic solutions to accelerate medical business by combining services in the fields of Medical Data Science, Market Access, and Medical Content Solutions. MedEngine’s customers are the world’s leading pharmaceutical and health technology companies and innovative healthcare start-up companies.
For more information, please visit www.medengine.fi or follow us on Twitter @MedEngineAgency.
Subscribe to releases from MedEngine Oy
Subscribe to all the latest releases from MedEngine Oy by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from MedEngine Oy
MedEngine and THL Biobank join forces to combine world-class biobanking with comprehensive medical research services11.6.2020 11:42:30 EEST | Tiedote
THL Biobank, a nationwide biobank hosted by the Finnish Institute for Health and Welfare, and MedEngine Oy, a company specialized in high-quality medical data science services, announce a collaboration initiative to combine extensive biobank resources and capabilities with in-depth knowledge of scientific research design and execution.
MedEngine ja DRA Consulting yhteistyöhön Market Access -palveluissa: tutkimustietoa ja strategista osaamista liiketoiminnan moottoriksi4.10.2018 10:00:00 EEST | Tiedote
Suomalaiset lääkealan asiantuntijapalveluihin erikoistuneet DRA Consulting Oy ja MedEngine Oy ovat aloittaneet Pohjoismaat kattavan yhteistyön. Yritysten keskeisenä tavoitteena on kehittää entistä tehokkaampia Market Access -palveluita yhdistämällä tosielämän tutkimustietoa strategiseen Market Access -osaamiseen.
MEDENGINE OY HUIPPUTULOKSEEN VUONNA 2017 LÄÄKETIETEELLISTÄ TUTKIMUSTA, MARKKINOINTIA JA STRATEGIAA YHDISTÄVILLÄ PALVELUILLA22.5.2018 11:28:32 EEST | Tiedote
Korkeatasoisiin lääketieteellisiin asiantuntijapalveluihin erikoistunut MedEngine Oy teki erinomaisen taloudellisen tuloksen vuonna 2017. Yrityksen liikevaihto kasvoi 61 prosenttia 1,6 miljoonaan euroon, mikä tekee MedEngine Oy:stä nopeimmin kasvavan suomalaisen lääketeollisuuden ja terveysteknologian asiantuntijapalveluihin erikoistuneen yrityksen.* Yrityksen liikevoittoprosentti ennen veroja oli 20,5 prosenttia. Vuonna 2014 perustetun yrityksen liikevoittoprosentti on ylittänyt 20 prosenttia sen jokaisena neljänä toimintavuotena.